Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.
about
Biomarkers of progestin therapy resistance and endometrial hyperplasia progression.The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps.Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study.
P2860
Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Down-regulation of bcl-2 is a ...... nt of endometrial hyperplasia.
@en
type
label
Down-regulation of bcl-2 is a ...... nt of endometrial hyperplasia.
@en
prefLabel
Down-regulation of bcl-2 is a ...... nt of endometrial hyperplasia.
@en
P2093
P356
P1433
P1476
Down-regulation of bcl-2 is a ...... nt of endometrial hyperplasia.
@en
P2093
P304
P356
10.1006/GYNO.1998.5336
P407
P577
1999-04-01T00:00:00Z